Literature DB >> 22385482

Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.

Dong Dong1, Roland Ako, Ming Hu, Baojian Wu.   

Abstract

The UDP-glucuronosyltransferase (UGT) enzyme catalyzes the glucuronidation reaction which is a major metabolic and detoxification pathway in humans. Understanding the mechanisms for substrate recognition by UGT assumes great importance in an attempt to predict its contribution to xenobiotic/drug disposition in vivo. Spurred on by this interest, 2D/3D-quantitative structure activity relationships and pharmacophore models have been established in the absence of a complete mammalian UGT crystal structure. This review discusses the recent progress in modeling human UGT substrates including those with multiple sites of glucuronidation. A better understanding of UGT active site contributing to substrate selectivity (and regioselectivity) from the homologous enzymes (i.e. plant and bacterial UGTs, all belong to family 1 of glycosyltransferase (GT1)) is also highlighted, as these enzymes share a common catalytic mechanism and/or overlapping substrate selectivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22385482      PMCID: PMC4390583          DOI: 10.3109/00498254.2012.663515

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  55 in total

1.  Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human UGT1A6 and UGT1A9.

Authors:  Brian T Ethell; Sean Ekins; Jibo Wang; Brian Burchell
Journal:  Drug Metab Dispos       Date:  2002-06       Impact factor: 3.922

Review 2.  Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases.

Authors:  Michael H Court
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

Review 3.  Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

Authors:  S Ekins; M J de Groot; J P Jones
Journal:  Drug Metab Dispos       Date:  2001-07       Impact factor: 3.922

4.  The chemical modification of human liver UDP-glucuronosyltransferase UGT1*6 reveals the involvement of a carboxyl group in catalysis.

Authors:  E Battaglia; C Senay; S Fournel-Gigleux; R Herber; G Siest; J Magdalou
Journal:  FEBS Lett       Date:  1994-06-13       Impact factor: 4.124

5.  Pharmacophore and quantitative structure activity relationship modelling of UDP-glucuronosyltransferase 1A1 (UGT1A1) substrates.

Authors:  Michael J Sorich; Paul A Smith; Ross A McKinnon; John O Miners
Journal:  Pharmacogenetics       Date:  2002-11

6.  Mutational analysis of the Medicago glycosyltransferase UGT71G1 reveals residues that control regioselectivity for (iso)flavonoid glycosylation.

Authors:  Xian-Zhi He; Xiaoqiang Wang; Richard A Dixon
Journal:  J Biol Chem       Date:  2006-09-18       Impact factor: 5.157

Review 7.  N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.

Authors:  Sanna Kaivosaari; Moshe Finel; Mikko Koskinen
Journal:  Xenobiotica       Date:  2011-03-24       Impact factor: 1.908

8.  Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A.

Authors:  Dong Li; Sylvie Fournel-Gigleux; Lydia Barré; Guillermo Mulliert; Patrick Netter; Jacques Magdalou; Mohamed Ouzzine
Journal:  J Biol Chem       Date:  2007-10-23       Impact factor: 5.157

Review 9.  The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families.

Authors:  Anna Radominska-Pandya; Stacie M Bratton; Matthew R Redinbo; Michael J Miley
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

10.  The crystal structure of two macrolide glycosyltransferases provides a blueprint for host cell antibiotic immunity.

Authors:  David N Bolam; Shirley Roberts; Mark R Proctor; Johan P Turkenburg; Eleanor J Dodson; Carlos Martinez-Fleites; Min Yang; Benjamin G Davis; Gideon J Davies; Harry J Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-21       Impact factor: 11.205

View more
  7 in total

1.  Enzymatic detoxication, conformational selection, and the role of molten globule active sites.

Authors:  Matthew T Honaker; Mauro Acchione; Wei Zhang; Bengt Mannervik; William M Atkins
Journal:  J Biol Chem       Date:  2013-05-06       Impact factor: 5.157

2.  Overcoming Drug Resistance through the Development of Selective Inhibitors of UDP-Glucuronosyltransferase Enzymes.

Authors:  Michael J Osborne; Luciana Coutinho de Oliveira; Laurent Volpon; Hiba Ahmad Zahreddine; Katherine L B Borden
Journal:  J Mol Biol       Date:  2018-11-11       Impact factor: 5.469

3.  Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences.

Authors:  Ryan W Dellinger; Angela M Gomez Garcia; Frank L Meyskens
Journal:  Drug Metab Pharmacokinet       Date:  2013-08-20       Impact factor: 3.614

4.  Identification of flavone glucuronide isomers by metal complexation and tandem mass spectrometry: regioselectivity of uridine 5'-diphosphate-glucuronosyltransferase isozymes in the biotransformation of flavones.

Authors:  Scott A Robotham; Jennifer S Brodbelt
Journal:  J Agric Food Chem       Date:  2013-02-08       Impact factor: 5.279

5.  1H, 13C and 15N chemical shift assignments of the C-terminal domain of human UDP-Glucuronosyltransferase 2B7 (UGT2B7-C).

Authors:  Michael J Osborne; Amanda K Rahardjo; Laurent Volpon; Katherine L B Borden
Journal:  Biomol NMR Assign       Date:  2021-04-18       Impact factor: 0.731

6.  The Fusarium metabolite culmorin suppresses the in vitro glucuronidation of deoxynivalenol.

Authors:  Lydia Woelflingseder; Benedikt Warth; Immina Vierheilig; Heidi Schwartz-Zimmermann; Christian Hametner; Veronika Nagl; Barbara Novak; Bojan Šarkanj; Franz Berthiller; Gerhard Adam; Doris Marko
Journal:  Arch Toxicol       Date:  2019-05-02       Impact factor: 5.153

7.  Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors.

Authors:  E E J Kasteel; K Darney; N I Kramer; J L C M Dorne; L S Lautz
Journal:  Arch Toxicol       Date:  2020-05-15       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.